Report: L'Occitane, Obagi Medical, Oriflame stand out as the best personal care takeover candidates
(Thomson Reuters ONE) -
In a report from London on Thursday, Bloomberg's Gaurav Panchal issued a report
to investors in which Berenberg names L'Occitane International SA, Obagi Medical
Products, Inc. (OMPI) and Oriflame Cosmetics SA (OFLMY) as the listed companies
most likely to attract quality bid offers.
"Few Household & Personal Care offer the correct mix of scale, fit, 'buzz',
synergy potential to attract interest from major industry players, Berenberg
says."
Earlier this week, Obagi Medical shareholders overwhelmingly voted against
ratifying its Rights Plan, which was carefully considered and recommended by
leading proxy advisory firm, Institutional Shareholder Services.
The move may set the table for the company to be acquired in short order.
Berenberg says the three publicly listed companies currently stand out as the
best takeover candidates while Coty and Unilever are likely to remain most
aggressive buyers in the space.
In mid-May, Coty Inc. withdrew a $10.7 billion offer for Avon Products Inc.
(AVP), the world's largest door-to-door cosmetics seller.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Equity Briefing via Thomson Reuters ONE
[HUG#1618258]
Datum: 08.06.2012 - 03:12 Uhr
Sprache: Deutsch
News-ID 154500
Anzahl Zeichen: 1748
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 818 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Report: L'Occitane, Obagi Medical, Oriflame stand out as the best personal care takeover candidates"
steht unter der journalistisch-redaktionellen Verantwortung von
Equity Briefing (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
